| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECH | Common Stock | Options Exercise | $505K | +13.4K | +34.33% | $37.70 | 52.4K | Jan 27, 2025 | Direct | |
| transaction | TECH | Common Stock | Sale | -$906K | -11.7K | -22.39% | $77.19 | 40.7K | Jan 27, 2025 | Direct | F1 |
| transaction | TECH | Common Stock | Sale | -$129K | -1.66K | -4.08% | $77.95 | 39K | Jan 27, 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECH | Stock Option (Right to Buy) | Options Exercise | $0 | -13.4K | -100% | $0.00 | 0 | Jan 27, 2025 | Common Stock | 13.4K | $37.70 | Direct | F3 |
| holding | TECH | Stock Option (Right to Buy) | 84.3K | Jan 27, 2025 | Common Stock | 84.3K | $44.33 | Direct | F3 | |||||
| holding | TECH | Stock Option (Right to Buy) | 110K | Jan 27, 2025 | Common Stock | 110K | $47.60 | Direct | F3 | |||||
| holding | TECH | Stock Option (Right to Buy) | 116K | Jan 27, 2025 | Common Stock | 116K | $66.97 | Direct | F3 | |||||
| holding | TECH | Stock Option (Right to Buy) | 25.9K | Jan 27, 2025 | Common Stock | 25.9K | $120.46 | Direct | F4 | |||||
| holding | TECH | Performance Restricted Stock Units | 6.98K | Jan 27, 2025 | Common Stock | 6.98K | Direct | F5, F6 | ||||||
| holding | TECH | Performance Stock Options (Right to Buy) | 21.7K | Jan 27, 2025 | Common Stock | 21.7K | $94.52 | Direct | F6 | |||||
| holding | TECH | Stock Options (Right to Buy) | 28.9K | Jan 27, 2025 | Common Stock | 28.9K | $94.52 | Direct | F7 | |||||
| holding | TECH | Performance Restricted Stock Units | 8.87K | Jan 27, 2025 | Common Stock | 8.87K | Direct | F5, F8 | ||||||
| holding | TECH | Performance Stock Options (Right to Buy) | 23.9K | Jan 27, 2025 | Common Stock | 23.9K | $84.61 | Direct | F8 | |||||
| holding | TECH | Stock Options (Right to Buy) | 29.4K | Jan 27, 2025 | Common Stock | 29.4K | $84.61 | Direct | F9 | |||||
| holding | TECH | Stock Options (Right to Buy) | 38.3K | Jan 27, 2025 | Common Stock | 38.3K | $52.83 | Direct | F10 | |||||
| holding | TECH | Performance Restricted Stock Units | 9.42K | Jan 27, 2025 | Common Stock | 9.42K | Direct | F5, F8 | ||||||
| holding | TECH | Performance Stock Options (Right to Buy) | 25.9K | Jan 27, 2025 | Common Stock | 25.9K | $68.54 | Direct | F8 | |||||
| holding | TECH | Stock Options (Right to Buy) | 51.9K | Jan 27, 2025 | Common Stock | 51.9K | $68.54 | Direct | F11 | |||||
| holding | TECH | Performance Restricted Stock Units | 51.3K | Jan 27, 2025 | Common Stock | 51.3K | Direct | F5, F12 | ||||||
| holding | TECH | Restricted Stock Units | 25.6K | Jan 27, 2025 | Common Stock | 25.6K | Direct | F5, F13 | ||||||
| holding | TECH | Stock Options (Right to Buy) | 69.1K | Jan 27, 2025 | Common Stock | 69.1K | $74.91 | Direct | F14 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.67 to $77.66 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.69 to $78.08 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | Fully exercisable. |
| F4 | Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. |
| F6 | Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| F7 | Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025. |
| F8 | Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| F9 | Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. |
| F10 | Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. |
| F11 | Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. |
| F12 | Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| F13 | 8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. |
| F14 | Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. |